Gilead has rescinded its request for orphan status for its potential COVID-19 antiviral remdesivir amid a furore over its pricing should it get to market.
Video consultations with GPs are a viable alternative during social distancing measures, according to research from the University of Warwick, although technical challenges and lack of reso
As the global COVID-19 outbreak continues to tighten its grip, people with underlying respiratory conditions such as cystic fibrosis (CF) are particularly vulnerable.
Scientists from the University of Oxford say they have identified a potential vaccine for the SARS-CoV-2 coronavirus that is the cause of the COVID-19 epidemic, which has claimed more than
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.